it is a second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, it exerts greater binding affinity than the first-generation compounds. it shows peroxisome proliferator-activated receptor (PPAR) gamma agonistic activity, has a short half-life and is excreted in both the bile and urine. 
